Drug interactions

被引:37
作者
Boobis, Alan [1 ]
Watelet, Jean-Baptiste [2 ]
Whomsley, Rhys [3 ]
Benedetti, Margherita Strolin [4 ]
Demoly, Pascal [5 ]
Tipton, Keith [6 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Div Med, Dept Expt Med & Toxicol, London W2O NN, England
[2] Univ Ghent, State Univ Ghent Hosp, Dept Otorhinolaryngol Head & Neck Surg, Ghent, Belgium
[3] Shire Pharmaceut, Biosci, Basingstoke, Hants, England
[4] UCB Pharma SA, F-92705 Colombes, France
[5] Univ Hosp Montpellier, Hosp Amaud Villeneuve, INSERM, U657, F-34295 Montpellier 5, France
[6] Trinity Coll Dublin, Dept Biochem, Dublin 2, Ireland
关键词
Drug-drug interactions; drug-diet interactions; P450; transporters; enzyme induction; enzyme inhibition; dietary amines; PREGNANE-X-RECEPTOR; HUMAN LIVER-MICROSOMES; AMINE OXIDASE SSAO; ST-JOHNS-WORT; VITRO CYTOCHROME-P450 INHIBITION; FLAVIN-CONTAINING MONOOXYGENASES; HISTIDINE-DECARBOXYLASE GENE; MECHANISM-BASED INACTIVATION; ISCHEMIA-REPERFUSION INJURY; IMMORTALIZED FA2N-4 CELLS;
D O I
10.1080/10837450902891550
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Drugs for allergy are often taken in combination with other drugs, either to treat allergy or other conditions. In common with many pharmaceuticals, most such drugs are subject to metabolism by P450 enzymes and to transmembrane transport. This gives rise to considerable potential for drug-drug interactions, to which must be added consideration of drug-diet interactions. The potential for metabolism-based drug interactions is increasingly being taken into account during drug development, using a variety of in silico and in vitro approaches. Prediction of transporter-based interactions is not as advanced. The clinical importance of a drug interaction will depend upon a number of factors, and it is important to address concerns quantitatively, taking into account the therapeutic index of the compound.
引用
收藏
页码:486 / 527
页数:42
相关论文
共 374 条
[1]
Ahrens F, 2002, INFLAMM RES, V51, pS83
[2]
MONOAMINE-OXIDASE INHIBITORS AND THE CHEESE EFFECT [J].
ANDERSON, MC ;
HASAN, F ;
MCCRODDEN, JM ;
TIPTON, KF .
NEUROCHEMICAL RESEARCH, 1993, 18 (11) :1145-1149
[3]
Tissue activity and cellular localization of human semicarbazide-sensitive amine oxidase [J].
Andrés, N ;
Lizcano, JM ;
Rodríguez, MJ ;
Romera, M ;
Unzeta, M ;
Mahy, N .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2001, 49 (02) :209-217
[4]
Computational models for predicting interactions with cytochrome p450 enzyme [J].
Arimoto, Rieko .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (15) :1609-1618
[5]
Effects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation of carcinogenic activity of N-nitrosodimethylamine in kidney and lung [J].
Arinc, Emel ;
Arslan, Sevki ;
Bozcaarmutlu, Azra ;
Adali, Orhan .
FOOD AND CHEMICAL TOXICOLOGY, 2007, 45 (01) :107-118
[6]
Averill-Bates DA, 2008, INT J ONCOL, V32, P79
[7]
ALDEHYDE DEHYDROGENASE AND CYTOTOXICITY OF PURIFIED BOVINE SERUM AMINE OXIDASE AND SPERMINE IN CHINESE-HAMSTER OVARY CELLS [J].
AVERILLBATES, DA ;
AGOSTINELLI, E ;
PRZYBYTKOWSKI, E ;
MONDOVI, B .
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1994, 72 (1-2) :36-42
[8]
An evaluation of the dose-dependent inhibition of CYP1A2 by rofecoxib using theophylline as a CYP1A2 probe [J].
Bachmann, K ;
White, D ;
Jauregui, L ;
Schwartz, JI ;
Agrawal, NGB ;
Mazenko, R ;
Larson, PJ ;
Porras, AG .
JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (10) :1082-1090
[9]
Inhibition constants, inhibitor concentrations and the prediction of inhibitory drug drug interactions: Pitfalls, progress and promise [J].
Bachmann, KA .
CURRENT DRUG METABOLISM, 2006, 7 (01) :1-14
[10]
Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice [J].
Bailey, D. G. ;
Dresser, G. K. ;
Leake, B. F. ;
Kim, R. B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (04) :495-502